227 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Amar
    Amar
  4. Norton
    Norton
  5. Kris
    Kris
  6. Morris
    Morris
  7. Mulhall
    Mulhall
  8. Papanicolaou
    Papanicolaou
  9. Tap
    Tap
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (97)
  3. Surgery (34)
  4. Survivorship Research (33)
  5. Genitourinary Oncology Service (27)
  6. Division of Subspecialty Medicine (23)
  7. Population Sciences Research Program (20)
  8. Epidemiology and Biostatistics (18)
  9. Hematologic Malignancies, Division of (18)
  10. Breast Medicine Service (17)
  1. "double blind procedure"
Formats
  1. Journal Article (219)
  2. Conference Paper (3)
  3. Correspondence (3)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (97)
  3. Surgery (34)
  4. Survivorship Research (33)
  5. Genitourinary Oncology Service (27)
  6. Division of Subspecialty Medicine (23)

More Groups

People
  1. Howard Scher (10)
  2. Robert Motzer (10)
  3. David Amar (7)
  4. Jose Baselga (7)
  5. Larry Norton (7)
  6. Genovefa Papanicolaou (6)

More People

Years
  1. 2025 (4)
  2. 2024 (21)
  3. 2023 (13)
  4. 2022 (12)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Lancet Oncology (20)
  3. New England Journal of Medicine (17)
  4. Clinical Cancer Research (9)
  5. Lancet (8)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. Elsevier Science, Inc. (37)
  2. Elsevier Inc. (28)
  3. American Society of Clinical Oncology (21)
  4. Oxford University Press (19)
  5. Lippincott Williams & Wilkins (17)
  6. Massachusetts Medical Society (17)

More Publishers

Results (227)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): A multicentre, randomised, double-blind, placebo-controlled, phase 3 study
    Journal Article

    Abou-Alfa, G. K.; Macarulla, T.; Javle, M. M.; Kelley, R. K.; Lubner, S. J.; Adeva, J.; Cleary, J. M.; Catenacci, D. V.; Borad, M. J.; Bridgewater, J.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: Results from TAGS
    Journal Article

    Tabernero, J.; Alsina, M.; Shitara, K.; Doi, T.; Dvorkin, M.; Mansoor, W.; Arkenau, H. T.; Prokharau, A.; Ghidini, M.; Faustino, C.; more...
    Gastric Cancer (2020)

    Fulltext@MSK | Save
  • Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: The ANNOUNCE randomized clinical trial
    Journal Article

    Tap, W. D.; Wagner, A. J.; Schöffski, P.; Martin-Broto, J.; Krarup-Hansen, A.; Ganjoo, K. N.; Yen, C. C.; Abdul Razak, A. R.; Spira, A.; Kawai, A.; more...
    JAMA - Journal of the American Medical Association (2020)

    Fulltext@MSK | Save
  • Assessment of adverse events from the patient perspective in a phase 3 metastatic castration-resistant prostate cancer clinical trial
    Journal Article

    Dueck, A. C.; Scher, H. I.; Bennett, A. V.; Mazza, G. L.; Thanarajasingam, G.; Schwab, G.; Weitzman, A. L.; Rogak, L. J.; Basch, E.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Complementary low-level laser therapy for breast cancer-related lymphedema: A pilot, double-blind, randomized, placebo-controlled study
    Journal Article

    Kilmartin, L.; Denham, T.; Fu, M. R.; Yu, G.; Kuo, T. T.; Axelrod, D.; Guth, A. A.
    Lasers in Medical Science (2020)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib
    Journal Article

    Hammel, P.; Kindler, H. L.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for cancer therapy-associated paronychia
    Journal Article

    Capriotti, K. D.; Anadkat, M.; Choi, J.; Kaffenberger, B.; McLellan, B.; Barone, S.; Kukoyi, O.; Goldfarb, S.; Lacouture, M.
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: Results of a phase 3, randomized, controlled trial
    Journal Article

    Montillo, M.; Illés, A.; Robak, T.; Pristupa, A. S.; Wach, M.; Egyed, M.; Delgado, J.; Jurczak, W.; Morschhauser, F.; Schuh, A.; more...
    Health and Quality of Life Outcomes (2019)

    Fulltext@MSK | Save
  • Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: A randomized, dose-ranging, double-blind, phase 2 study
    Journal Article

    Papanicolaou, G. A.; Silveira, F. P.; Langston, A. A.; Pereira, M. R.; Avery, R. K.; Uknis, M.; Wijatyk, A.; Wu, J.; Boeckh, M.; Marty, F. M.; more...
    Clinical Infectious Diseases (2019)

    Fulltext@MSK | Save
  • Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer
    Journal Article

    Khorana, A. A.; Soff, G. A.; Kakkar, A. K.; Vadhan-Raj, S.; Riess, H.; Wun, T.; Streiff, M. B.; Garcia, D. A.; Liebman, H. A.; Belani, C. P.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save